Intellia Therapeutics(NTLA) - 2024 Q4 - Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Brittany Chaves - Senior Manager of Investor Relations John Leonard - President and Chief Executive Officer David Lebwohl - Chief Medical Officer Edward Dulac - Executive Vice President and Chief Financial Officer Birgit Schultes - Executive Vice President and Chief Scientific Officer Conference Call Participants Mani Foroohar - Leerink Partners Maury Raycroft - Jefferies Lisa Walter ...